Department of Bioproducts and Biosystems, Aalto University School of Chemical Engineering, P.O.Box 16100, Espoo, Finland.
Technical Research Center of Finland, P.O.Box 1000, Espoo, Finland.
Glycoconj J. 2018 Feb;35(1):31-40. doi: 10.1007/s10719-017-9794-3. Epub 2017 Sep 13.
Fucosylated oligosaccharides have an important role in maintaining a healthy immune system and homeostatic gut microflora. This study employed a commercial β-galactosidase in the production of fucose-containing galacto-oligosaccharides (fGOS) from lactose and fucose. The production was optimized using experiment design and optimal conditions for a batch production in 3-liter scale. The reaction product was analyzed and the produced galactose-fucose disaccharides were purified. The structures of these disaccharides were determined using NMR and it was verified that one major product with the structure Galβ1-3Fuc and two minor products with the structures Galβ1-4Fuc and Galβ1-2Fuc were formed. Additionally, the product composition was defined in more detail using several different analytical methods. It was concluded that the final product contained 42% total monosaccharides, 40% disaccharides and 18% of larger oligosaccharides. 290 μmol of fGOS was produced per gram of reaction mixture and 37% of the added fucose was bound to fGOS. The fraction of fGOS from total oligosaccharides was determined as 44%. This fGOS product could be used as a new putative route to deliver fucose to the intestine.
岩藻糖基低聚糖在维持健康的免疫系统和肠道微生物群落稳态方面起着重要作用。本研究采用商业β-半乳糖苷酶,从乳糖和岩藻糖生产含有岩藻糖的半乳糖低聚糖(fGOS)。通过实验设计和 3 升规模分批生产的优化条件,对生产进行了优化。对反应产物进行了分析,并对所产生的半乳糖-岩藻糖二糖进行了纯化。通过 NMR 确定了这些二糖的结构,证实了主要产物具有 Galβ1-3Fuc 的结构,还有两种次要产物具有 Galβ1-4Fuc 和 Galβ1-2Fuc 的结构。此外,还使用几种不同的分析方法更详细地定义了产物组成。结果表明,最终产物含有 42%的总单糖、40%的二糖和 18%的较大寡糖。每克反应混合物可生产 290 μmol 的 fGOS,添加的岩藻糖有 37%结合到 fGOS 中。fGOS 占总寡糖的比例为 44%。这种 fGOS 产品可作为向肠道输送岩藻糖的新途径。